SETTLEMENT AGREEMENTSettlement Agreement • April 8th, 2022 • Massachusetts
Contract Type FiledApril 8th, 2022 JurisdictionThis Settlement Agreement is made and entered into on April 8, 2022 by and between plaintiffs Meijer, Inc. and Meijer Distribution, Inc. (“Plaintiffs”), individually and on behalf of the direct purchaser classes defined below (who, together with Plaintiffs are referred to collectively as the “Direct Purchaser Classes”), by and through Hagens Berman Sobol Shapiro LLP attorneys Thomas M. Sobol and Kristen A. Johnson, and Hilliard & Shadowen LLP attorney Steve Shadowen, in their capacity as attorneys and lead class counsel (“Lead Class Counsel”) for the Direct Purchaser Classes in In re Ranbaxy Generic Drug Application Antitrust Litigation, No. 19-md-02878-NMG (the “Action”), and defendants Ranbaxy, Inc. and Sun Pharmaceutical Industries Limited (collectively, “Ranbaxy”)1 by and through Kirkland & Ellis LLP attorneys Jay P. Lefkowitz and Devora W. Allon. This Settlement Agreement is intended to, and upon occurrence of the Effective Date will, fully, finally, and forever resolve, compromis